Fate Therapeutics Inc (FATE)

CapEx to Revenue

3.84%

Quarterly · Period ending:

FATE logo

FATE CapEx to Revenue

Latest reported3.84%
FATE Quarterly CapEx/Revenue (67.23% → 3.84%)
High-resolution chart · PNG

FATE capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
3.8425%
18.3988%
87.0709%
126.5365%
71.4211%
73.4193%
5.2688%
16.1028%
0.7531%
4.4675%
10.7995%
29.0638%
235.6913%
5.4391%
15.0532%
57.9134%
54.6067%
54.7627%
107.6161%
103.5852%
101.5434%
35.7297%
14.2929%
12.6224%
11.6377%
42.5447%
92.434%
52.0379%
63.7203%
66.3374%
67.2486%
70.5653%
27.0691%
17.9337%
77.6047%
35.2827%
40.0585%
15.0925%
3.8948%
3.2164%
20.0584%
13.4644%
16.5428%
63.8402%
64.7416%
0%
0%
0%
0%
0%
-15.448%
11.0048%
22.069%
1.4831%
45.8787%
67.2348%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.